Abstract
The susceptibility of 30 clinical isolates ofHelicobacter pylori to trospectomycin, ampicillin, metronidazole, clarithromycin, azitromycin and clindamycin under varying pH conditions was evaluated. An acidic environment was shown to affect unfavourably the activity of all the antimicrobial agents tested. This pH effect was most marked for the two macrolides and for clindamycin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastric and peptic ulceration. Lancet 1984, i: 1311–1315.
Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 1990, 335: 1233–1235.
Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Murray R, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori. Lancet 1988, ii: 1437–1441.
Grayson ML, Eliopoulos GM, Ferraro MJ, Moellering RC: Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agents. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 888–889.
Malanoski GJ, Eliopoulos GM, Ferraro MJ, Moellering RC: Effect of pH variation on the susceptibility ofHelicobacter pylori to three macrolide antimicrobial agents and temafloxacin. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 131–133.
Queiroz DMM, Mendes ENM, Rocha GA: Indicator medium for isolation ofCampylobacter pylori. Journal of Clinical Microbiology 1987, 25: 2378–2379.
Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E: Evaluation of the E Test for quantitative antimicrobial susceptibility testing ofHelicobacter pylori. Journal of Clinical Microbiology 1991, 29: 2072–2075.
Talley NJ, Ormand JE, Frie CA, Zinsmeister A: Stability of pH gradients in vivo across the stomach inHelicobacter pylori gastritis, dyspepsia and health. American Journal of Gastroenterology 1992, 87: 590–594.
McNulty CAM, Dent JC, Ford GA, Wilkinson SP: Inhibitory antimicrobial concentrations againstCampylobacter pylori in gastric mucosa. Journal of Antimicrobial Chemotherapy 1988, 22: 729–738.
Veldhuyzen van Zanten SJD, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH: Secretion of intravenously administered antibiotics in gastric juice: implications for management ofHelicobacter pylori. Journal of Clinical Pathology 1992, 45: 225–227.
Harrison JD, Jones JA, Morris DL: Azithromycin levels in plasma and gastric tissue, juice and mucus. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 862–864.
Glupczynski Y: Failure of azithromycin to eradicateCampylobacter pylori from the stomach because of acquired resistance during treatment. American Journal of Gastroenterology 1990, 85: 98–99.
Westblom TU, Midkiff BR, Czinn SJ: In vitro susceptibility ofHelicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A). New Antimicrobial Agents 1993, 12: 560–562.
Barry AL, Jones RN, Thornsberry C: Antibacterial activity of trospectomycin and initial evaluations of disk diffusion susceptibility tests. Antimicrobial Agents and Chemotherapy 1989, 33: 569–572.
Vogt K, Rodloff AC, Hahn H: Combined activity of trospectomycin and colloidal bismuth subcitrate againstHelicobacter pylori in vitro. Infection 1991, 19: 138–139.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Debets-Ossenkopp, Y.J., Namavar, F. & MacLaren, D.M. Effect of an acidic environment on the susceptibility ofHelicobacter pylori to trospectomycin and other antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 14, 353–355 (1995). https://doi.org/10.1007/BF02116532
Issue Date:
DOI: https://doi.org/10.1007/BF02116532